Skip to main content
OpenTrials
Completed

NCT Number: NCT05211245

Comparative Evaluation of Continuous and Pulse Mode of Ultrasound Therapy in Myalgia of Maxillofacial Region

Pain and trismus caused by Myalgia in masticatory muscles are one of the prime concerns for the patients. Various studies have been performed using US therapy for myofascial pain syndrome of head & neck region. US is a non-invasive frequently used physical agent which increase blood flow in tissues and collagen fibers ability to grow, & reduce muscle spasm with its thermal effect. It is difficult to imply the results of studies performed in muscles of other regions of body to the maxillofacial region because of the superficial placement of these muscles.US is being frequently used for myofascial pain, but there is an absence of a consensus regarding the frequency and mode of administration available in literature for administration of this therapy in maxillofacial region. Therefore, the present study has been designed to compare the therapeutic effect of two modes of US i.e., continuous and pulsed at 3 MHz frequency

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Myalgia Muscular Diseases Musculoskeletal Diseases Musculoskeletal Pain Nervous System Diseases Neurologic Manifestations Neuromuscular Diseases Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms Trigger Point

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

PGIDS

Rohtak, Haryana, 124001, India

About this study

Pain and trismus caused by Myalgia in masticatory muscles are one of the prime concerns for the patients. There are limited number of studies in the literature that have evaluated therapeutic ultrasound for the management of Myalgia of maxillofacial region. Various studies have been performed, evaluating the treatment of myofascial pain with trigger point in other parts of body including neck region using ultrasound, but not all patient of myalgia present with trigger point. The most frequently used ultrasound frequencies are 1 and 3MHz. 1 MHz has more penetrating power as compared to 3MHz. Masticatory muscles being superficial in location need less penetrating waves as compared to other muscles. The ultrasound can be applied in a continuous or pulsed manner. There are studies supporting the fact that Continuous ultrasound therapy is more efficient in reducing myofascial pain syndrome of trapezius muscle at rest because it produces a heating effect in the muscles, that help in breaking the spasm. On the other hand, the pulsed mode, produces more of penetrating effect and acts on the gas bubbles of the soft tissues, thereby decreasing the inflammation. However, the two methods have not yet been compared in maxillofacial muscles. Therefore, this study aims to compare the outcome of therapeutic Ultrasound administered at 3MHz frequency in continuous & pulse modes in myalgia of maxillofacial region

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients diagnosed with myalgia within orofacial muscle as per DC/TMD (Ia and Ib)
  • Patient's consent for participation in this study.

Exclusion criteria

  • Patients with epilepsy/seizures
  • Patients with radiographic changes suggestive of pathological conditions of temporomandibular joint (TMJ).
  • Patients with undiagnosed orofacial pain
  • Any sort of skin lesion at the site where electrode is to be placed.
  • Therapeutic ultrasound must not be applied over areas of impaired circulation, ischemic areas, or areas having sensory deficit.
  • Sites of active infection
  • Patients with metal prosthesis
  • Patients with Becks depression score >25 will be excluded.

Treatment and study plan

Therapeutic Ultrasound

Device

Therapeutic ultrasound ranges from 750,000 to 3,300,000 Hz (0.75 to 3.3 MHz). Depending upon the output parameters it may produce effects like increase tissue extensibility, reduction of calcium deposits, reduction of pain & muscle spasm by altering nerve conduction velocity & changes in cell membrane permeability along with increased rate of tissue repair & wound healing.There are two main types of ultrasound therapy: thermal and mechanical. Thermal effect which is a result of continuous mode of US therapy causes transient increase in the flexibility of collagenous structures including ligaments, tendons & joint capsules, thus leading to decrease in the pain & muscle spasm, stiffness of the joint & temporary increase in the blood flow. Pulsed mode of US results in nonthermal effect i.e., micro massage like which lead to segmental analgesia due to decreased central & peripheral sensitization.

Primary outcomes

  1. To evaluate the intensity of pain in each group

    Time frame: Base line

    Visual Analog Scale (VAS) 0n a scale of 0-10

  2. To evaluate the intensity of pain in each group

    Time frame: 2 weeks

    Visual Analog Scale (VAS) 0n a scale of 0-10

  3. To evaluate the intensity of pain in each group

    Time frame: 4weeks

    Visual Analog Scale (VAS) 0n a scale of 0-10

  4. To evaluate the intensity of pain in each group

    Time frame: 6 weeks

    Visual Analog Scale (VAS) 0n a scale of 0-10

  5. To evaluate the intensity of pain in each group

    Time frame: 3 months

    Visual Analog Scale (VAS) 0n a scale of 0-10

  6. To assess pressure pain sensitivity of muscles in the two groups.

    Time frame: Base line

    Algometer

  7. To assess pressure pain sensitivity of muscles in the two groups.

    Time frame: 2 weeks

    Algometer

  8. To assess pressure pain sensitivity of muscles in the two groups.

    Time frame: 4 weeks

    Algometer

  9. To assess pressure pain sensitivity of muscles in the two groups.

    Time frame: 6 weeks

    Algometer

  10. To assess pressure pain sensitivity of muscles in the two groups.

    Time frame: 3 months

    Algometer

Secondary outcomes

  1. To evaluate the maximal mouth opening and functional movements

    Time frame: Base line

    Digital Vernier calliper

  2. To evaluate the maximal mouth opening and functional movements

    Time frame: 2 weeks

    Digital Vernier calliper

  3. To evaluate the maximal mouth opening and functional movements

    Time frame: Base line ,2 weeks,4 weeks ,6 weeks, 3 months post treatment

    Digital Vernier calliper

  4. To evaluate patient psychological status

    Time frame: Base line ,2 weeks,4 weeks ,6 weeks, 3 months post treatment

    Beck depression inventory

  5. To evaluate quality of life

    Time frame: Base line ,2 weeks,4 weeks ,6 weeks, 3 months post treatment

    Oral Health Impact Profile (OHIP 14)

  6. To assess the need for pain medication

    Time frame: Base line ,2 weeks,4 weeks ,6 weeks, 3 months post treatment

    number of medication needed

Sponsors and collaborators

Lead sponsor

Postgraduate Institute of Dental Sciences Rohtak

Other

Registry information

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Jan 27, 2022
Registry last updated
Mar 14, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.